194 related articles for article (PubMed ID: 3880687)
1. Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication.
Lepäntalo M
Clin Pharmacol Ther; 1985 Jan; 37(1):7-12. PubMed ID: 3880687
[TBL] [Abstract][Full Text] [Related]
2. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.
Roberts DH; Tsao Y; McLoughlin GA; Breckenridge A
Lancet; 1987 Sep; 2(8560):650-3. PubMed ID: 2887941
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
5. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
Silke B; Nelson GI; Ahuja RC; Taylor SH
Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
[TBL] [Abstract][Full Text] [Related]
6. Labetalol and pindolol in the treatment of hypertension: a comparative study.
Romo M; Halttunen P; Saarinen P; Sarna S
Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
[TBL] [Abstract][Full Text] [Related]
7. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol.
Johnston GD; Finch MB; Shanks RG
Eur J Clin Pharmacol; 1986; 30(6):649-52. PubMed ID: 3533562
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Pugsley DJ; Nassim M; Armstrong BK; Beilin L
Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
[TBL] [Abstract][Full Text] [Related]
10. Effects of labetalol and propranolol on the peripheral circulation in hypertensive patients.
Nyberg G; Berglund G
Acta Med Scand Suppl; 1982; 665():93-101. PubMed ID: 6961763
[TBL] [Abstract][Full Text] [Related]
11. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
[TBL] [Abstract][Full Text] [Related]
12. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
McNeil JJ; Louis WJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
[TBL] [Abstract][Full Text] [Related]
13. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
[TBL] [Abstract][Full Text] [Related]
14. Labetalol compared with prindolol plus hydraliazine in the treatment of hypertension: a double-blind cross-over study.
Barnett AJ; Kalowski S; Guest C
Med J Aust; 1978 Jan; 1(2):105-9. PubMed ID: 349319
[TBL] [Abstract][Full Text] [Related]
15. Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication.
Lepäntalo M
Br J Clin Pharmacol; 1984 Jul; 18(1):90-3. PubMed ID: 6378235
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of acebutolol and labetalol on peripheral hemodynamics in healthy volunteers.
Wurm M; Kantelip JP; Duchene-Marullaz P
Fundam Clin Pharmacol; 1988; 2(5):405-11. PubMed ID: 3069682
[TBL] [Abstract][Full Text] [Related]
17. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
Ades PA; Wolfel EE; Hiatt WR; Fee C; Rolfs R; Brammell HL; Horwitz LD
Eur J Clin Pharmacol; 1989; 36(1):5-10. PubMed ID: 2917588
[TBL] [Abstract][Full Text] [Related]
18. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
Lehtonen A; Allonen H; Kleimola T
Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
